BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Daewoong Pharma partners with Vitalli Bio for new autoimmune drug (DWP213388)

Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech...

April 28, 2023 | News

Indica Labs and Lunit Form Strategic Alliance for Integrated Digital Pathology AI Workflows

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...

April 27, 2023 | News

MGI Announces New Customer Experience Center in South Korea with BMS

"Genomics is an exploding and popular field in South Korea, and we at MGI are excited to join hands with BMS to welcome researchers and partners in th...

April 27, 2023 | News

Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...

April 26, 2023 | News

Bridge Biotherapeutics Receives FDA Approval for First-in-Human Study of BBT-207, a 4th Gen EGFR TKI.

The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed The latest preclinical data explored the antitumor effica...

April 24, 2023 | News

Samyang Holdings partners with LG Chem for innovative cancer therapeutics.

Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on Thursday, April 20th, for development of nove...

April 20, 2023 | News

Korea Health Industry Development Institute hosts Korean Pavilion at 2023 HIMSS Global Health Conference

Korea Health Industry Development Institute (President Cha Soon-do, hereinafter referred to as the "Institute") announced that they will run the Korea...

April 19, 2023 | News

West Korea Announces Ready Pack™ Containment Solution Extension at COPHEX 2023

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced the extension o...

April 18, 2023 | News

Bridge Bio Announces First Patient Dosed in Phase 2a Trial of BBT-877 for Idiopathic Pulmonary Fibrosis Treatment

In the Phase 1 study in 2019, BBT-877, a potent autotaxin (ATX) inhibitor, demonstrated its ability to inhibit lysophosphatidic acid (LPA) production by as...

April 13, 2023 | News

Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023

Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), will be exhibiting at Korea Pharm&Bio, Apri...

April 13, 2023 | News

Genexine's GX-E4 Phase 3 trial shows non-inferiority to Mircera for anemia treatment, presented at WCN2023

Kidneys are responsible for 90% of the EPO produced in our bodies. CKD-induced anemia is caused by the failure to produce EPO (erythropoietin) due to long-...

April 12, 2023 | News

BIORCHESTRA Hires David Oxley as Chief Business Officer to Expand Leadership Team

Adding additional strengths to the company's executive team, Mr. Oxley brings extensive experience in developing corporate strategy, leading cross-borders ...

April 06, 2023 | News

Standigm, Institut Pasteur Korea identify drug candidates for drug-resistant TB with grant

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Instit...

April 05, 2023 | News

iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model

According to the company's explanation, bacteriophages have been mainly used for R&D on bacterial infectious diseases, but recently the scope of applic...

April 04, 2023 | News

Stay Connected